T-cell prolymphocytic leukemia: An aggressive T cell malignancy with frequent cutaneous tropism

Journal of the American Academy of Dermatology

Volumn 55, Issue 3, 2006, Pages 467-477

  Magro, Cynthia M ^a   Morrison, Carl D ^a   Heerema, Nyla ^a   Porcu, Pierluigi ^b   Sroa, Novie ^c   Deng, April C ^d  

^a Departments of Pathology

^b Hematology and Oncology ^*

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD52 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE ANTIGEN; MYC PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLEEDING; CHROMOSOME 14; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; EDEMA; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MICROSCOPY; PHENOTYPE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PURPURA; SKIN BIOPSY; SKIN DEFECT; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; ANEUPLOIDY; ANTIGENS, CD; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOGENETIC ANALYSIS; FACE; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; GLYCOPROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PROLYMPHOCYTIC; LEUKEMIA, T-CELL, CHRONIC; MALE; MIDDLE AGED; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN;

EID: 33747058017     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.060     Document Type: Article

References (45)

1. Galton D.A.G., Goldman J.M., Wiltshaw E., Catovsky D., Henry K., and Goldenberg J. Prolymphocytic leukaemia. Br J Haematol 27 (1974) 7-23
2. Catovsky D., Galetto J., Okos A., Galton D.A.G., Wiltshaw E., and Stathaopoulos G. Prolymphocytic leukaemia of B and T cell type. Lancet 2 (1973) 232-234
3. Matutes E., Garcia Talavera J., O'Brien M., and Catovsky D. The morphological spectrum of T-prolymphocytic leukemia. Br J Haematol 64 (1986) 111-124
4. Toyota S., Nakamura N., and Dan K. Small cell variant T-cell prolymphocytic leukemia with a gamma delta immunophenotype. Int J Hematol 81 (2005) 66-68
5. Jaffe E.S., Harris N., Stein H., and Vardiman J.W. Tumours of hematopoietic and lymphoid tissues. World Health Organization Classification of Tumours (2001), IARC Press, Lyon, France
6. Hoyer J.D., Ross C.W., Li C.Y., Witzig T.E., Gascoyne R.D., Dewald G.W., et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood 86 (1995) 1163-1169
7. Mallett R.B., Matutes E., Catovsky D., Maclennan K., Mortimer P.S., and Holden C.A. Cutaneous infiltration in T-cell prolymphocytic leukemia. Br J Dermatol 132 (1995) 263-266
8. DeBelilovsky C., Guillaume J.C., Gilles E., Bosq J., Hayat M., Desvignes V., et al. Cutaneous manifestations of T-cell prolymphocytic leukemia. Ann Dermatol Venerreol 116 (1989) 889-891
9. Volk J.R., Kjeldsberg C.R., Eyre H.J., and Marty J. T-cell prolymphocytic leukemia. Clinical and immunology characterization. Cancer 52 (1983) 2049-2054
10. Beltran Fernandez L., di Martino Ortiz B., Gil Herrera J., Lopez-Herce J.A., de Portugal Alvarez J., and Menarguez Palanca J. Cutaneous erythematous rash as first manifestation of T-cell prolymphocytic lymphatic leukemia. An Med Interna 19 (2002) 126-129
11. Serra A., Estrach M.T., Marti R., Villamor N., Rafel M., and Montserrat E. Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukemia. Acta Derm Venereol 78 (1998) 198-200
12. Thomas A., Dompmartin A., Troussard X., Moreau A., Manard C., and Leroy D. Cutaneous localization of T-cell prolymphocytic leukemia. Ann Dermatol Venereol 122 (1995) 526-529
13. De Belilovsky C., Guillaume J.C., Gilles E., Bosq J., Hayat M., Desvignes V., et al. Cutaneous manifestations of T-cell prolymphocytic leukemia. Ann Dermatol Venereol 116 (1989) 889-891
14. Logan R.A., and Smith N.P. Cutaneous presentation of prolymphocytic leukemia. Br J Dermatol 118 (1988) 553-558
15. Assaf C., Hummel M., Dippel E., Schwartz S., Geilen C.C., Harder L., et al. Common clonal T-cell origin in a patient with T-prolymphocytic leukemia and associated cutaneous T-cell lymphomas. Br J Haematol 120 (2003) 488-491
16. Matutes E., Brito-Babapulle V., Swansbury J., Ellis J., Morilla R., Dearden C., et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78 (1991) 3269-3274
17. Garand R., Goasguen J., Brizard A., Buisine J., Charpentier A., Claisse J.F., et al. Indolent course as a relatively frequent presentation in T-prolymphocytic leukemia. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 103 (1998) 488-494
18. Matutes E. T-cell Prolymphocytic Leukemia. Cancer Control 5 (1998) 19-24
19. Ginaldi L., Matutes E., Farahat N., De Martinis M., Morilla R., and Catvosky D. Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry. Br J Haematol 93 (1996) 921-927
20. Nakajima H., Oki M., and Ando K. Unusual lymphoma manifestations: case 3. T-cell prolymphocytic leukemia. Clin Oncol 22 (2004) 560-562
21. + chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia. Eur J Haematol 71 (2003) 224-230
22. Ginaldi L., De Martinis M., Matutes E., Farahat N., Morilla R., Dyer M.J., et al. Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H. Leuk Res 22 (1998) 185-191
23. Isobe M., Russo G., Haluska F.G., and Corce C.M. Cloning of the gene encoding the delta subunit of the human T-cell receptor reveals its physical organization within the alpha-subunit locus and its involvement in chromosome translocations in T-cell malignancy. Proc Natl Acad Sci U S A 85 (1988) 3933-3937
24. Mossafa H., Brizard A., Huret J.L., Brizard F., Lessard M., Guilhot F., et al. Trisomy 8q due to i (8q) or der (8) t (8; 8) is a frequent lesion in T-prolymphocytic leukemia: four new cases and a review of the literature. Br J Haematol 86 (1994) 780-785
25. Brito-Babpulle V., and Catovsky D. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 55 (1991) 1-9
26. Pekarsky Y., Hallas C., and Croce C.M. The role of TCL1 in human T-cell leukemia. Oncogene 20 (2001) 5638-5643
27. Thick J., Metcalfe J.A., Mark Y.F., Beatty D., Minegishi M., Dyer M.J., et al. Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukemic and non-leukemic T cells from ataxia telangiectasia patients. Oncogene 12 (1996) 379-386
28. Thick J., and Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood 87 (1996) 423-438
29. Maljaie S.H., Brito-Babpulle V., Matutes E., Hiorns L.R., De Shouwer P.J., and Catovsky D. Expression of c-myc oncoprotein in chronic T cell leukemias. Leukemia 9 (1995) 1694-1699
30. Morrison C., Radmacher R., Mohammed N., Suster D., Auer H., Jones S., et al. MYC amplification and polysomy in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol 23 (2005) 9369-9376
31. Monni O., and Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma 40 (2001) 259-266
32. Sugimoto T., Imoto S., Matsuo Y., Kojima K., Yasukawa M., Murayama T., et al. T-cell receptor gamma delta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype. Ann Hematol 80 (2001) 749-751
33. Herling M., Khoury J.D., Washington L.T., Duvic M., Keating M., and Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 104 (2004) 328-335
34. Jones D., and Dorfman D.M. Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma. Leuk Lymphoma 40 (2001) 449-459
35. Yamashita Y., Yatabe Y., Tsuzuki T., Nakayama A., Hasegawa Y., Kojima H., et al. Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod Pathol 11 (1998) 313-323
36. Sokol L., and Loughran Jr. T.P. Large granular lymphocyte leukemia. Oncologist 11 (2006) 263-273
37. Didamandidou E., Cohen P.R., and Kurzrock R. Mycosis fungoides and Sézary syndrome. Blood 88 (1996) 2385-2409
38. DiGiuseppe J.A., Louie D.C., Williams J.E., Miller D.T., Griffin C.A., Mann R.B., et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 21 (1997) 1223-1230
39. Ko Y.H., Kim S.H., and Ree H.J. Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation. Histopathology 33 (1998) 547-553
40. Ginarte M., Abalde M.T., Peteiro C., Fraga M., Alonso N., and Toribio J. Blastoid NK cell leukemia/lymphoma with cutaneous involvement. Dermatology 201 (2000) 268-271
41. Rakozy C.K., Mohamed A.N., Vo T.D., Khatib G., Long P.M., Eilender D., et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypical, cytogenetically, and clinically diverse. Am J Clin Pathol 116 (2001) 168-176
42. Aoyama Y., Yamane T., Hino M., Ohta K., Nakamae H., Yamamura R., et al. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement. Ann Hematol 80 (2001) 752-754
43. DuBois S.G., Etzell J.E., Matthay K.K., Robbins E., and Banerjee A. Pediatric acute blastic natural killer cell leukemia. Leuk Lymphoma 43 (2002) 901-906
44. Petrella T., Comeau M.R., Maynadie M., Couillault G., De Muret A., Maliszewski C.R., et al. Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 26 (2002) 852-862
45. Khoury J.D., Medeiros L.J., Manning J.T., Sulak L.E., Bueso-Ramos C., and Jones D. CD56 (+) TdT (+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 94 (2002) 2401-2408